Silenced Antibody Based Anti Met Constructs For The Treatment Of Tumors And Metastasis

Pierre Fabre Medicament
Application Awaiting Examination App No 202517105446 Biotechnology

Patent information

IP India · live record
Application number
202517105446
Filing date
31 October 2025
Status
Application Awaiting Examination
Publication number
52/2025
Publication type
INA
Invention field
Biotechnology

Abstract

The present disclosure relates to novel silenced antibody-based therapeutic agent for the treatment of tumors and/or metastasis. The therapeutic agents of the present disclosure are monovalent and are specific for MET.

Applicants

1
France
PIERRE FABRE MEDICAMENT Les Cauquillous 81500 LAVAUR

Inventors

6
Germany
URLINGER, StefanieKreuzhofstr. 31 81476 München
Switzerland
KUNZ, ChristianHirzbodenweg 80 4052 Basel
Switzerland
OTTAVIANI, GiorgioAm Ausserberg 71 4125 Riehen
Switzerland
ULLAH, MohammedKonsumstrasse 3 4104 Oberwil
Germany
ROSPORT, KaiHans-Fischer-Str. 29 80339 München
France
LAINÉ, Anne-Laure6 Rue de la Concorde 68330 Huningue

Documents

Sign in to open
Application documents
1 202517105446-STATEMENT OF UNDERTAKING (FORM 3) [31-10-2025(online)].pdf 31 Oct 2025
3 202517105446-Sequence Listing in PDF [31-10-2025(online)].pdf 31 Oct 2025
4 202517105446-REQUEST FOR EXAMINATION (FORM-18) [31-10-2025(online)].pdf 31 Oct 2025
5 202517105446-PRIORITY DOCUMENTS [31-10-2025(online)].pdf 31 Oct 2025
6 202517105446-POWER OF AUTHORITY [31-10-2025(online)].pdf 31 Oct 2025
7 202517105446-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [31-10-2025(online)].pdf 31 Oct 2025
8 202517105446-FORM 18 [31-10-2025(online)].pdf 31 Oct 2025
9 202517105446-FORM 1 [31-10-2025(online)].pdf 31 Oct 2025
10 202517105446-DRAWINGS [31-10-2025(online)].pdf 31 Oct 2025
11 202517105446-DECLARATION OF INVENTORSHIP (FORM 5) [31-10-2025(online)].pdf 31 Oct 2025
12 202517105446-COMPLETE SPECIFICATION [31-10-2025(online)].pdf 31 Oct 2025
13 202517105446-Proof of Right [06-01-2026(online)].pdf 06 Jan 2026